CCK-8 assays showed reduced proliferation in the OE-TRIM6 groups of both MOLM-13 and Kasumi-1 cells at 48 and 72 hours, compared to the vector control group (Fig 7C), indicating that TRIM6 inhibits AML cell proliferation. The gene discussed is TRIM6; the disease is acute myeloid leukemia.